American College Of Surgeons - Inspiring Quality: Highest Standards, Better Outcomes

Commission on Cancer

The Commission on Cancer (CoC) is a consortium of professional organizations dedicated to improving survival and quality of life for cancer patients through standard setting, which promotes cancer prevention, research, education, and monitoring of comprehensive quality care.

The multidisciplinary CoC

  • Establishes standards to ensure quality, multidisciplinary, and comprehensive cancer care delivery in health care settings
  • Conducts surveys in health care settings to assess compliance with those standards
  • Collects standardized data from CoC-accredited health care settings to measure cancer care quality
  • Uses data to monitor treatment patterns and outcomes and enhance cancer control and clinical surveillance activities
  • Develops effective educational interventions to improve cancer prevention, early detection, cancer care delivery, and outcomes in health care settings.

Individuals and representatives of more than 50 cancer-related organizations comprise the membership of the CoC and contribute to the development of the CoC standards and accreditation program.

Today, there are more than 1,500 CoC-accredited cancer programs in the United States and Puerto Rico. CoC accreditation encourages hospitals, treatment centers, and other facilities to improve their quality of care through various cancer-related programs and activities. These programs are concerned with the full continuum of cancer—from prevention to survivorship and end-of-life-care—while addressing both survival and quality of life.

CoC Standard 6.4 Update

The Commission on Cancer has become aware of a cyber incident with one of our hospital registry software vendors. Due to the inability of the affected programs to submit data to the Rapid Cancer Reporting System for April and May 2021 to meet compliance with CoC Standard 6.4, the CoC will give all accredited programs a "pass" for submission for these two months.

  Learn More

Call for Data

The NCDB 2021 Call for Data for all CoC-accredited cancer programs will open June 1, 2021. Please review this communication for important information regarding the new reporting system, key dates in the submission process, and requirements for submission.

  Learn More

NCDB Tools 2021

The NCDB has released their NCDB Tools 2021 brochure. These tools are for use by CoC-accredited programs as a means by which to evaluate and compare the cancer care delivered to patients diagnosed and/or treated at their facility with that provided at the state, regional, and national levels.

  Learn More

New QI Project

CoC and NAPBC sites are invited to participate in an elective Plan/Do/Study/Act (PDSA) 2021 quality improvement project and clinical study. 

  Learn more

Synoptic Reporting Options

While compliance with CoC Standards 5.3–5.6 will not take effect until 2023, many programs are aware that it will take time to get electronic medical record synoptic reporting solutions in place. Programs are asking about new options available for synoptic operative reporting. We are providing the most current information about synoptic reporting solutions.

  Read more

Paper Competition

The Commission on Cancer is now accepting submissions for the annual Cancer Research Paper Competition. This year, papers can be submitted under one of two categories: clinical research or basic science. First, second, and third place winners will be selected from each category. Submission deadline is June 30.

  Learn more

2020 Standards Updated

An updated version of Optimal Resources for Cancer Care (2020 Standards) is now available. The February 2021 version includes the previously-announced updates to the NCDB submission standards. Also included in the updated manual are revisions to the Operative Standards (Standards 5.3-5.8).

  Learn More

2021 Requirements

In an email sent September 16, the specific standards required for implementation in 2021 as described in the Optimal Resources for Cancer Care (2020 Standards) were outlined. Programs scheduled for a site visit in 2022 will be reviewed on 2020 and 2021 program activity.

  Learn More

Brochure

Learn about how ACS Cancer Programs are improving outcomes for patients with cancer in our latest brochure.

  Download the brochure